Welcome to the first participants of the Spyryx HOPE-1 Study" /> Welcome to the first participants of the Spyryx HOPE-1 Study" />
The NICRF welcomes the first participants of the Spyryx HOPE-1 Study, December 2017.
Dr Damian Downey, Principal Investigator within the Centre for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, QUB, is undertaking a Randomized, Double-Blind, Placebo-Controlled, Phase II Study to evaluate the efficacy and safety of SPX-101 inhalation solution in subjects with Cystic Fibrosis.
Read more about the Spyryx Hope-1 Study.
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11